Mereon Bio

Mereon Bio LLC is a United States-based biotechnology company specializing in advanced drug-release and delivery technologies. The company's core technology portfolio includes a reversible ion-network-based drug-release platform, an electrically controlled sustained-release system, and a micro-mechanical stimulus-responsive release technology. Traditionally focused on B2B collaborations with global pharmaceutical companies for hospital and specialty applications, Mereon Bio recently expanded into the consumer healthcare market through a strategic technology transfer to Unexa Korea in early 2026. Its mission is to develop therapeutics that act longer and are delivered with greater precision, bridging the gap between clinical innovation and daily wellness. The company's platforms are designed to optimize formulation efficiency and improve user convenience across a range of medical and functional health applications.